Sharon A. Glynn

10.4k total citations · 1 hit paper
76 papers, 4.0k citations indexed

About

Sharon A. Glynn is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Sharon A. Glynn has authored 76 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 20 papers in Oncology and 20 papers in Physiology. Recurrent topics in Sharon A. Glynn's work include Nitric Oxide and Endothelin Effects (18 papers), Estrogen and related hormone effects (13 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Sharon A. Glynn is often cited by papers focused on Nitric Oxide and Endothelin Effects (18 papers), Estrogen and related hormone effects (13 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Sharon A. Glynn collaborates with scholars based in United States, Ireland and Italy. Sharon A. Glynn's co-authors include Francis Sullivan, Stefan Ambs, Sarah Ridge, David A. Wink, Lisa A. Ridnour, Robert Y.S. Cheng, Christopher Switzer, Francis J. Giles, Anthony J. Burke and Julie L. Heinecke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Sharon A. Glynn

76 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesenchymal stem cells: key players in cancer progression

2017 429 citations Francis Sullivan, Sharon A. Glynn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon A. Glynn United States	36	1.6k	971	850	671	596	76	4.0k
Sara Huerta‐Yépez Mexico	37	2.0k 1.2×	791 0.8×	811 1.0×	375 0.6×	736 1.2×	153	3.9k
William P. Bennett United States	35	2.5k 1.5×	1.3k 1.3×	2.0k 2.3×	470 0.7×	312 0.5×	62	5.0k
Tracy Robson United Kingdom	40	1.8k 1.1×	653 0.7×	638 0.8×	316 0.5×	518 0.9×	116	3.8k
David A. Foster United States	54	6.0k 3.6×	1.5k 1.5×	1.4k 1.6×	700 1.0×	608 1.0×	144	8.4k
Remco van Doorn Netherlands	35	1.8k 1.1×	853 0.9×	1.2k 1.4×	943 1.4×	1.4k 2.4×	128	5.3k
Joong Sup Shim Macao	33	3.2k 1.9×	792 0.8×	994 1.2×	163 0.2×	328 0.6×	85	5.0k
Georg Krupitza Austria	33	2.7k 1.7×	853 0.9×	1.4k 1.6×	165 0.2×	377 0.6×	134	5.0k
Bin Yan China	38	2.8k 1.7×	1.5k 1.6×	899 1.1×	293 0.4×	692 1.2×	179	4.9k
Fátima Baltazar Portugal	47	3.7k 2.3×	3.0k 3.0×	1.3k 1.5×	365 0.5×	588 1.0×	174	6.9k
Samuel K. Kulp United States	40	2.8k 1.7×	738 0.8×	1.0k 1.2×	182 0.3×	346 0.6×	120	4.4k

Countries citing papers authored by Sharon A. Glynn

Since Specialization

Citations

This map shows the geographic impact of Sharon A. Glynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon A. Glynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon A. Glynn more than expected).

Fields of papers citing papers by Sharon A. Glynn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon A. Glynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon A. Glynn. The network helps show where Sharon A. Glynn may publish in the future.

Co-authorship network of co-authors of Sharon A. Glynn

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon A. Glynn. A scholar is included among the top collaborators of Sharon A. Glynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon A. Glynn. Sharon A. Glynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Jenny C., et al.. (2024). The impact of nitric oxide on HER family post-translational modification and downstream signaling in cancer. Frontiers in Physiology. 15. 1358850–1358850. 4 indexed citations

Alsharabasy, Amir M., Durgadas Cherukaraveedu, Jonas Warneke, et al.. (2024). Facile Synthesis of Hemin Derivatives with Modulated Aggregation Behaviour and Enhanced Nitric‐Oxide Scavenging Properties as New Therapeutics for Breast Cancer. SHILAP Revista de lepidopterología. 4(11). 2400237–2400237. 2 indexed citations

Reddy, T. P., Sharon A. Glynn, Timothy R. Billiar, David A. Wink, & Jenny C. Chang. (2022). Targeting Nitric Oxide: Say NO to Metastasis. Clinical Cancer Research. 29(10). 1855–1868. 37 indexed citations

Abbas, Mohammad, Faizan Haider Khan, Sushma Verma, et al.. (2021). Role of miRNAs in cervical cancer: A comprehensive novel approach from pathogenesis to therapy. Journal of Gynecology Obstetrics and Human Reproduction. 50(9). 102159–102159. 10 indexed citations

Glynn, Sharon A., et al.. (2019). Diabetes Mellitus and Gender Have a Negative Impact on the Outcome of Hip Fracture Surgery—A Pilot Study. Journal of Orthopaedic Research®. 38(4). 834–842. 6 indexed citations

Garrido, Pablo, et al.. (2017). Inflammation and Nitrosative Stress Effects in Ovarian and Prostate Pathology and Carcinogenesis. Antioxidants and Redox Signaling. 26(18). 1078–1090. 24 indexed citations

Thomas, Douglas D., Julie L. Heinecke, Lisa A. Ridnour, et al.. (2015). Signaling and stress: The redox landscape in NOS2 biology. Free Radical Biology and Medicine. 87. 204–225. 106 indexed citations

Deegan, Shane, et al.. (2014). A close connection between the PERK and IRE arms of the UPR and the transcriptional regulation of autophagy. Biochemical and Biophysical Research Communications. 456(1). 305–311. 47 indexed citations

Cheng, Robert Y.S., Debashree Basudhar, Lisa A. Ridnour, et al.. (2014). Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways. Nitric Oxide. 43. 17–28. 19 indexed citations

10.

Sullivan, Francis, et al.. (2014). Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice?. International Journal of Cancer. 137(6). 1249–1257. 102 indexed citations

11.

Wallace, Tiffany A., Aaron J. Schetter, Tiffany H. Dorsey, et al.. (2014). Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers. Carcinogenesis. 35(9). 2074–2083. 79 indexed citations

12.

McLaughlin, Fiona, Frank Giles, Francis Sullivan, et al.. (2013). The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance. British Journal of Cancer. 109(8). 2131–2141. 10 indexed citations

13.

Switzer, Christopher, Robert Y.S. Cheng, Lisa A. Ridnour, et al.. (2012). Dithiolethiones Inhibit NF-κB Activity via Covalent Modification in Human Estrogen Receptor–Negative Breast Cancer. Cancer Research. 72(9). 2394–2404. 31 indexed citations

14.

Flores‐Santana, Wilmarie, Debra J. Salmon, Sonia Donzelli, et al.. (2011). The Specificity of Nitroxyl Chemistry Is Unique Among Nitrogen Oxides in Biological Systems. Antioxidants and Redox Signaling. 14(9). 1659–1674. 79 indexed citations

15.

Glynn, Sharon A., Robyn L. Prueitt, Lisa A. Ridnour, et al.. (2010). COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer. BMC Cancer. 10(1). 626–626. 59 indexed citations

16.

Glynn, Sharon A., Brenda J. Boersma, Tiffany M. Howe, et al.. (2009). A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide. Clinical Cancer Research. 15(12). 4165–4173. 38 indexed citations

17.

Dowling, Paul, Paula Meleady, Andrew Dowd, et al.. (2006). Proteomic analysis of isolated membrane fractions from superinvasive cancer cells. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1774(1). 93–101. 70 indexed citations

18.

Schreiber, George B., Usha Sharma, David J. Wright, et al.. (2005). First year donation patterns predict long‐term commitment for first‐time donors. Vox Sanguinis. 88(2). 114–121. 122 indexed citations

19.

Higgins, Martha, Steven Kleinman, George B. Schreiber, et al.. (2004). Comparison of demographic and donation profiles and transfusion‐transmissible disease markers and risk rates in previously transfused and nontransfused blood donors. Transfusion. 44(8). 1243–1251. 11 indexed citations

20.

Schreiber, George B., Sharon A. Glynn, Catharie C. Nass, et al.. (2003). Prevalence of transfusion‐transmissible viral infections in first‐time US blood donors by donation site. Transfusion. 43(6). 705–712. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact